Trial Details

COMPLETED
Basic Information
Clinical ID c3224
Identifier NCT02367183
Trial Title A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn Disease
Interventions DRUG: GED-0301|DRUG: Placebo
Participant Information
Sponsor Celgene
City Los Angeles
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2015-04-08
Primary Completion Date 2016-09-06
Completion Date 2017-12-14